ArticleSurgical neurology international2026
Cerebellar hemangioblastoma in a patient with neurofibromatosis type 1: A case report.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hemangioblastomas (HBs) are benign, highly vascular tumors that predominantly arise in the posterior fossa and are typically associated with von Hippel-Lindau disease. Their occurrence in individuals with neurofibromatosis type 1 (NF1) is exceptional and represents a diagnostic challenge. Case Description: We report the case of a 27-year-old patient with NF1 who developed a cerebellar HB. Magnetic resonance imaging revealed a cystic lesion involving the right cerebellar hemisphere and vermis with an enhancing mural nodule. Preoperative imaging findings were suggestive of HB. Tumor resection was performed through a midline suboccipital approach, achieving complete removal of the mural nodule, with histopathological confirmation of the diagnosis. Follow-up imaging demonstrated persistence of the cystic component without a residual enhancing nodular lesion. Given these findings and clinical considerations, adjuvant radiotherapy was administered in 23 sessions, resulting in significant clinical improvement. Conclusion: This case does not aim to establish a genetic association between NF1 and HB, but rather to highlight the diagnostic and therapeutic challenges posed by tumors outside the typical NF1 spectrum. It underscores the importance of considering overlapping tumor predisposition syndromes, as well as the need for comprehensive neuroaxis evaluation, long-term surveillance, and multidisciplinary management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.